Guide for patients & caregivers
Squamous Cell Carcinoma of the Skin on Biopsy: What Next?
Squamous cell carcinoma of the skin on biopsy explained: in situ (Bowen's) vs invasive, risk features in outline, treatment options and follow-up skin checks.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does squamous cell carcinoma on a skin biopsy mean?
A skin biopsy showing squamous cell carcinoma (SCC) means the pathologist found a skin cancer arising from keratinocytes, the cells of the outer skin layer. It is the second most common skin cancer. The British Association of Dermatologists (BAD) says most SCCs are low risk and can be cured, while a small number come back or spread to lymph nodes or elsewhere.
This guide covers SCC of the skin only, not SCC of the mouth, lung or other organs. It explains common report wording to help a conversation with the treating team; it cannot read an individual report or decide treatment.
When should a skin change be checked sooner?
Healthdirect notes that untreated SCC can grow quickly, so changes should not wait for a routine date. Contact the treating team or a GP promptly if:
- The spot grows, becomes painful, bleeds easily, turns into an open sore or develops a lump.
- A patch of Bowen's disease starts to bleed, ulcerate or form a lump. The NHS says this could be a sign it has become invasive SCC and advises not waiting for a follow-up appointment.
- A new lump appears under the skin near the treated area or in the nearby neck, armpit or groin, since SCC can occasionally spread to lymph nodes.
- A new scaly, crusty or non-healing patch appears anywhere, or a treated site changes.
- The person has a weakened immune system, for example after an organ transplant, and notices any new skin change. The NCI notes SCC can behave more aggressively in this group.
What is the difference between SCC in situ (Bowen's disease) and invasive SCC?
SCC in situ, also called Bowen's disease or stage 0, means the abnormal cells are found only in the epidermis, the top layer of skin. The NHS describes it as a very early, slow-growing form that is easily treatable, usually appearing as a red, scaly patch. Left untreated, it can turn into invasive SCC; the NHS estimates this happens in up to 1 in 20 to 1 in 30 people.
Invasive SCC means cancer cells have grown into the deeper layers of skin. This is the form that carries a small risk of spreading, so the report usually gives more detail about the tumour. Ask which of the two the biopsy shows, because the treatment options and follow-up differ.
What features make a squamous cell carcinoma higher risk?
The pathology report and examination give clues to the chance of the SCC coming back or spreading. The NCI's professional summary lists features linked with a less favourable outlook, including:
- Tumour size (diameter) and depth or thickness of invasion.
- Perineural invasion: cancer cells growing along or around nerves.
- Grade or differentiation: 'poorly differentiated' cells look less like normal skin cells than 'well differentiated' ones.
- Site: for example the lip or ear, and SCCs arising in old scars, burns, chronic ulcers or previously irradiated skin.
- A weakened immune system, which the NCI notes can make even small SCCs behave more aggressively.
How is squamous cell carcinoma of the skin treated?
Treatment depends on whether the SCC is in situ or invasive, its size, site and risk features, and the person's overall health. The BAD says surgery is usually recommended for SCC. Options described by the BAD, NHS and Cleveland Clinic include:
- Surgical excision with a margin of normal skin, usually under local anaesthetic, sometimes with a skin graft. The pathologist then checks whether the margins are clear.
- Curettage and cautery: scraping the SCC away and sealing the skin, used in some cases.
- Mohs micrographic surgery: removal in stages with immediate microscope checks, used for some SCCs, often on the face.
- Radiotherapy, given over several sessions, for example where surgery would be difficult.
- For Bowen's disease: freezing, prescription creams, photodynamic therapy, curettage or excision; sometimes careful monitoring alone.
- For SCC that has spread: combinations of surgery, radiotherapy and medicines such as immunotherapy or chemotherapy, planned by a specialist team.
What happens after treatment, and how often are skin checks needed?
According to the BAD, people with low-risk SCC usually do not need ongoing specialist follow-up, while higher-risk SCCs are typically followed up regularly for one to two years. The team may also examine nearby lymph nodes, and the NCI notes that an ultrasound of the nearby lymph nodes may be done.
Having one SCC raises the chance of another skin cancer. The BAD estimates about a 40% chance of another skin cancer within five years after a low-risk SCC, and higher after a high-risk one. Regular self-checks of the skin are strongly advised. Healthdirect suggests people at high risk have a skin check at least every 12 months, and yearly specialist checks after an organ transplant.
Can further squamous cell carcinomas be prevented?
UV light is the main cause of skin SCC. The BAD and Healthdirect advise protective clothing, a hat that shades the face, neck and ears, sunglasses, shade in the middle of the day, avoiding sunburn and sunbeds, and a high-protection (SPF 30 or higher) broad-spectrum sunscreen as an extra layer. Treating areas of scaly sun damage, such as actinic keratoses and Bowen's disease, may also reduce SCC risk. Cleveland Clinic lists stopping smoking among prevention steps.
Questions to ask about a squamous cell carcinoma biopsy
These questions may help when talking with the dermatologist, surgeon or GP. Bring a copy of the pathology report if possible.
- Is my SCC in situ (Bowen's disease) or invasive?
- Is it considered low risk or high risk, and which features on the report matter most?
- Were the margins clear, or is more treatment needed?
- Do the lymph nodes need to be examined or scanned?
- Which treatment suits this site, and what will the scar and recovery be like?
- Will I have follow-up, for how long, and what changes should make me get in touch sooner?
How comparing similar cases on SameCase can help
On SameCase, patients and verified doctors share de-identified cases. Seeing how others with in situ or invasive SCC at a similar site discussed margins, Mohs surgery or follow-up can help in preparing questions. Other people's cases cannot show what an individual report means or what treatment is needed, so decisions stay with the treating team.
Sources and further reading
- British Association of Dermatologists: Squamous cell carcinoma patient information leaflet (April 2022)
- NHS: Bowen's disease (reviewed October 2022)
- NHS: Treatment for non-melanoma skin cancer (reviewed September 2026)
- National Cancer Institute: Skin cancer treatment (PDQ), patient version
- National Cancer Institute: Skin cancer treatment (PDQ), health professional version
- Healthdirect Australia: Squamous cell carcinoma (reviewed December 2024)
- Cleveland Clinic: Squamous cell carcinoma (updated April 2022)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.